PeptideLabs Logo
PeptideLabs
All profiles

Bacteriostatic Water

Support solution · Other substances

Not a peptide or active compound. Labelling, sterility and intended use vary; no mixing instructions are provided here.

Not a peptide medicine
LibraryNo account · this device only

Also known as: BAC Water · Bacteriostatic water for injection

Use at a glance

Bacteriostatic Water

Not a peptide or active compound. Labelling, sterility and intended use vary; no mixing instructions are provided here.

Medicine instructions · named product only

Product or source: Bacteriostatic Water · DailyMed

What amount?
no active dose of its own
How often?
per the exact prescribing information
What time of day?
Time of day not stated here
In what setting?
Not applicable
How is it used?
Only a diluent for a compatible medicine, not an active treatment or an injection on its own.
Does it need mixing?
Bacteriostatic water is already a liquid. Its suitability and volume depend on the medicine being prepared.
View preparationCheck sources
More factsSupport solution · Other substances
Classification
Support solution · Other substances
Research focus
Not a peptide or active compound. Labelling, sterility and intended use vary; no mixing instructions are provided here.
Evidence
Unclear
Status
Not a peptide medicine

This entry is not a single peptide, or its use depends on diagnosis, product form or composition. A blanket peptide dose would be misleading.

Schedule explained in detailNo uniform peptide protocol

Amount status

Not an active substance and has no dose of its own. Bacteriostatic water is only a sterile multi-dose diluent for compatible medicines.

Profile evidence level: unclear.

Timing

The required liquid volume comes exclusively from the target medicine's prescribing information or a validated pharmacy instruction.

No individual recommendation.

Cycle/duration

No cycle. Bacteriostatic water alone must not be injected.

No individual recommendation.

Mixing & calculations

Bacteriostatic water is already a liquid. Its suitability and volume depend on the medicine being prepared.

All preparation informationProduct details and calculation examples from the available sources.

Typical approved products contain 0.9% benzyl alcohol; certain formats 1.1%. BAC water does not make a research peptide sterile, authentic, stable or safe, and it is contraindicated in newborns.

Reconstitution & quantitiesOpen basics, units and sources
Explained in very simple termsBefore reading any number: this page reports what a product label, study or online community states. It does not say what any person should use.

Amount

mg or µg describe the mass of a substance. That is not the same as ml of fluid or U on a syringe. The number is only the amount stated by the identified source.

Interval

The interval only describes the time stated between two points. For example, once every 7 days does not mean daily and never justifies catching up or doubling.

Cycle

A cycle is a stated period that may include breaks. A community cycle proves neither effectiveness nor safety and does not prevent long-term risks.

Reconstitution

Reconstitution means mixing powder with a defined volume of fluid. This changes concentration, not the total amount in the vial. On U-100, 100 U equals exactly 1 ml of volume.

Not a guide to misuse

All community figures are shown only to place widely circulated online protocols in context. They are not instructions for self-use, injection, performance enhancement or any other misuse. Approved figures apply only to the exact named product, approved indication and medical supervision.

Research, risks & more detailsMechanism, adverse effects, storage, comparisons and common questions.

Mechanism: what is supported and what does not follow

Sterile diluent product; not a peptide or active research compound

Bacteriostatic Water is classified as “Sterile diluent product; not a peptide or active research compound”. Not a peptide or active compound. Labelling, sterility and intended use vary; no mixing instructions are provided here. This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

Sterile diluent product

This concerns liquids that contain no active ingredient themselves but are used to prepare other products, similar to an empty vessel rather than its contents. Purity and sterility are typically studied, not a biological effect.

02

Product identity testing

This concerns laboratory analysis used to determine what a product actually contains, similar to checking the ingredients label against what's really inside the package. Researchers or analysts typically use chemical testing methods to identify and quantify the actual contents.

03

Ambiguous catalog naming

This concerns a vendor name that does not correspond to a single, scientifically defined substance, similar to a nickname that could refer to different things. Researchers and analysts examine what actual composition lies behind the name.

What communities discuss

These themes describe discussions and vendor claims. They do not prove benefit, safety, product identity or suitable use.

Compounding pharmacy discussion

This compares how individually prepared products from different compounding pharmacies differ in purity, concentration, and handling. Such comparisons are usually based on individual cases and do not replace standardised quality testing.

Source and purity discussion

Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.

Vendor marketing claims

Vendors often advertise products with broad efficacy claims, comparison tables against competitors, and customer quotes. Such marketing statements are driven by sales interest and do not constitute independent scientific proof of efficacy.

Adverse effects and safety risks

  • Risks depend particularly on actual identity, dosage form, concentration, excipients and medical rationale. Vitamins, cofactors and diluents can also cause adverse effects or interactions.
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Do not self-use / obtain clinical review

  • Allergy, kidney/liver disease, pregnancy, relevant medicines, and absent diagnosis or product identity must be resolved before use.
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • Monitoring follows the specific medical purpose, such as confirming deficiency, organ function or tolerability. A blanket peptide lab panel is not meaningful.
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

Unclear

Labelling, sterility and intended use vary by manufacturer.

Clinical evidence

The actual composition or identity of the product is not reliably known, so the evidence picture cannot be properly assessed.

Bacteriostatic water is not a peptide or active compound but a sterile diluent product, unlike every other entry in this directory.

Storage and stability

  • Store the original product per the label, typically at 20–25 °C.
  • The post-puncture time limit comes from product/pharmacy guidance; '28 days' is not a universal rule.

Troubleshooting and common errors

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

Not a peptide medicine

This is not a standalone peptide active; product form and regulatory status need separate consideration.

WADA 2026

Bacteriostatic water is not prohibited; what matters is the dissolved active substance and, where relevant, the WADA M2 rule for infusions.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.

Back to all 64 profilesOpen scientific atlas profile